Evidence map›Paper›PMID 27084424›Full record

ArticleTranslational oncology2016

Upregulation of RNA Processing Factors in Poorly Differentiated Lung Cancer Cells.

Kenneth G Geles, Wenyan Zhong, Siobhan K O'Brien, Michelle Baxter, Christine Loreth, Diego Pallares, Marc Damelin

Abstract read
In one paragraph

Article in Translational oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Organotypic Models of Lung Cancer.Current topics in microbiology and immunology · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kenneth G GelesPfizer Inc., Oncology-Rinat Research & Development, 401 N. Middletown Rd., Pearl River, NY 10965 USA.
Wenyan ZhongPfizer Inc., Oncology-Rinat Research & Development, 401 N. Middletown Rd., Pearl River, NY 10965 USA.
Siobhan K O'BrienPfizer Inc., Oncology-Rinat Research & Development, 401 N. Middletown Rd., Pearl River, NY 10965 USA.
Michelle BaxterPfizer Inc., Oncology-Rinat Research & Development, 401 N. Middletown Rd., Pearl River, NY 10965 USA.
Christine LorethPfizer Inc., Oncology-Rinat Research & Development, 401 N. Middletown Rd., Pearl River, NY 10965 USA.
Diego PallaresDiaxonhit, 65 Boulevard Massena,75013 Paris France.
Marc DamelinPfizer Inc., Oncology-Rinat Research & Development, 401 N. Middletown Rd., Pearl River, NY 10965 USA. Electronic address: marc.damelin@pfizer.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intratumoral heterogeneity in non-small cell lung cancer (NSCLC) has been appreciated at the histological and cellular levels, but the association of less differentiated pathology with poor clinical outcome is not understood at the molecular level. Gene expression profiling of intact human tumors fails to reveal the molecular nature of functionally distinct epithelial cell subpopulations, in particular the tumor cells that fuel tumor growth, metastasis, and disease relapse. We generated primary serum-free cultures of NSCLC and then exposed them to conditions known to promote differentiation: the air-liquid interface (ALI) and serum. The transcriptional network of the primary cultures was associated with stem cells, indicating a poorly differentiated state, and worse overall survival of NSCLC patients. Strikingly, the overexpression of RNA splicing and processing factors was a prominent feature of the poorly differentiated cells and was also observed in clinical datasets. A genome-wide analysis of splice isoform expression revealed many alternative splicing events that were specific to the differentiation state of the cells, including an unexpectedly high frequency of events on chromosome 19. The poorly differentiated cells exhibited alternative splicing in many genes associated with tumor progression, as exemplified by the preferential expression of the short isoform of telomeric repeat-binding factor 1 (TERF1), also known as Pin2. Our findings demonstrate the utility of the ALI method for probing the molecular mechanisms that underlie NSCLC pathogenesis and provide novel insight into posttranscriptional mechanisms in poorly differentiated lung cancer cells.

Identifiers

PMID27084424
PMCPMC4833891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.